What are the early signs of Ovarian Cancer recurrence

Early Signs of Ovarian Cancer Recurrence

Understanding the warning signs of recurrence is important for your ongoing care. According to the NCCN Guidelines for Ovarian Cancer, recurrent disease can be identified in three ways: clinically (through symptoms), biochemically (through blood tests), and through imaging studies.

Clinical Symptoms (What You Might Notice)

The NCCN Guidelines recommend that patients be educated about these symptoms, which may suggest recurrence:

• Pelvic pain - new or persistent pain in the pelvic area
• Bloating - abdominal swelling or feeling of fullness
• Early satiety - feeling full quickly when eating
• Bowel obstruction - difficulty with bowel movements or blockage symptoms
• Weight loss - unexplained loss of weight
• Fatigue - persistent tiredness that doesn't improve with rest

Important context: These symptoms can have many causes, but if they're new, frequent, or persistent, they warrant discussion with your healthcare team.

Biochemical Signs (Blood Test Markers)

CA-125 levels are commonly monitored after ovarian cancer treatment:

• An elevated or rising CA-125 may indicate biochemical recurrence (disease detected through blood work before symptoms appear)
• According to NCCN Guidelines, after an elevated CA-125 is detected, the median time until clinical recurrence is 2 to 6 months

Important note: The NCCN Guidelines emphasize that treating recurrence based solely on an elevated CA-125 in asymptomatic patients (those without symptoms) has not been shown to improve survival. Your doctor will discuss the pros and cons of CA-125 monitoring with you.

Imaging Findings

Your doctor may order imaging to look for recurrent disease:

• CT scans of chest, abdomen, and pelvis
• MRI imaging
• PET/CT scans
• Chest X-rays (if clinically indicated)

---

What Should You Do?

Questions to ask your healthcare team:

1. How often should I have CA-125 testing, and what level would be concerning?
2. What symptoms should prompt me to call you immediately versus scheduling a routine appointment?
3. If my CA-125 rises but I have no symptoms, what's your recommendation—treat immediately or monitor?
4. What imaging studies do you recommend for follow-up, and how often?
5. Are there any clinical trials available for recurrent ovarian cancer that might be appropriate for me?

---

Important Context from NCCN Guidelines

The NCCN Guidelines note that patients with ovarian cancer are often retreated with multiple courses of recurrence therapy over time. Treatment decisions depend on:

• Platinum sensitivity status - whether your cancer recurred more than 6 months (platinum-sensitive) or less than 6 months (platinum-resistant) after initial chemotherapy
• Your overall health and treatment tolerance
• Available treatment options

Your oncologist will determine the most appropriate approach for YOUR specific case based on the complete clinical picture, including your individual circumstances and preferences.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines for Ovarian Cancer (Version 3.2025)